FDA Approved: INCRELEX — Supplemental Application (Ipsen Biopharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for INCRELEX (mecasermin) from Ipsen Biopharmaceuticals, reflecting regulatory action for this product. The action updat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Failure Due to Igf 1 Deficiency
• Insulin-like Growth Factor Deficiency
• Laron Syndrome

Drugs mentioned

• INCRELEX (Mecasermin)

Snippet

SUPPL AP for INCRELEX (MECASERMIN)